World Pharmaceutical Sales Increase 5%

19 December 1994

Drug sales in the world's top nine pharmaceutical markets were 5% higher for the first nine months of 1994 than in the equivalent period last year, according to the latest figures from IMS International.

The USA remained the biggest market by far, registering sales to September of $36.5 billion, followed by Japan at $16.1 billion and Germany (the biggest market in the seven European countries included in the data) at $9.97 billion.

Surprisingly, considering the amount of attention health care reform and managed care issues have received from the industry over the past year, the USA also showed the largest market growth over the period, rising 8%. Also showing an increase of 8% was the somewhat smaller market in the UK, advancing to $4.07 billion compared to $3.7 billion in the first nine months 1993.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight